TFP Bureau, New Delhi, October 25, 2025: HLL Lifecare Limited (HLL), a Mini-Ratna Central Public Sector Enterprise under the Ministry of Health and Family Welfare, has reinforced its robust financial performance by declaring and paying a record dividend of ₹69.53 crore to the Government of India for the financial year 2024–25 — one of the highest dividends in the company’s history.
The dividend cheque was formally presented to Union Health and Family Welfare Minister Shri J.P. Nadda by Dr. Anitha Thampi, Chairperson of HLL Lifecare Limited. The event was attended by Minister of State for Health & Family Welfare Smt. Anupriya Patel, Union Health Secretary Smt. Punya Salila Srivastava, AS&FA Shri Hovyeda Abbas, Joint Secretary Shri Vijay Nehra, and senior HLL officials including Shri N. Ajit, Director (Marketing), and Shri Ramesh P, Director (Finance).
Commending the company’s performance, Shri Nadda described HLL as a “reliable hand in the field of medical and health services” and lauded its steadfast role in achieving the national vision of “accessible, affordable, and quality healthcare for all.” He highlighted that HLL and its subsidiaries, along with the AMRIT (Affordable Medicines and Reliable Implants for Treatment) Pharmacies, have become key players in transforming India’s healthcare delivery landscape.
“In the last 10 years alone, more than 6.7 crore people have benefitted from affordable medicines provided through AMRIT Pharmacies, collectively saving over ₹8,000 crore in out-of-pocket expenses,” Shri Nadda said, emphasizing HLL’s role in improving public access to essential medicines and surgical supplies.
During FY 2024–25, HLL recorded significant growth across its manufacturing and service divisions. The company’s revenue from operations rose to ₹4,500 crore, reflecting a 20% increase from the previous year, while its net worth climbed to ₹1,100 crore as of March 31, 2025. On a consolidated basis — including its subsidiaries HITES, GAPL, and Lifespring Hospitals — the HLL Group registered total revenues of ₹4,900 crore, marking a 19% year-on-year growth.
Established on March 1, 1966, HLL Lifecare Limited has evolved from a population control-focused enterprise to a diversified healthcare solutions provider, engaged in the manufacturing of contraceptives, pharmaceuticals, surgical products, and diagnostics, while also operating large-scale social marketing and health infrastructure projects.
Through initiatives such as AMRIT Pharmacies and health service collaborations, HLL continues to expand its reach across the country, ensuring that essential medical products remain accessible and affordable to all citizens.
As HLL marks its 60th year of service, it reaffirms its mission to strengthen India’s healthcare system through innovation, efficiency, and inclusivity—embodying the spirit of public service and national health advancement.
